Westchester Capital Management (New York)’s Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant CPUH.U Stock Holding History
Bought
Maintained
Sold
Other funds holding CPUH.U
PIF
SIM
LIM
HF
BCL
Westchester Capital Management (New York)'s CPUH.U Position: Q3 2022 in Review
Westchester Capital Management (New York) sold out of Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant (CPUH.U) in Q3 2022, closing a stake of 553,344 shares — an estimated $5.45M sold.
Westchester Capital Management (New York) first reported a position in CPUH.U in Q1 2021 and held it in 6 quarters. The position peaked at $5.61M in Q3 2021. 32 funds tracked by Wall St. Rank hold CPUH.U as of Q3 2022.
- Westchester Capital Management (New York) reported no remaining Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant position as of Q3 2022 after selling out during the quarter.
- Westchester Capital Management (New York) sold 553,344 Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant shares in Q3 2022, an estimated $5.45M.
- Westchester Capital Management (New York) first reported a position in Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant in Q1 2021 and held it in 6 quarters.
- Westchester Capital Management (New York)'s Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant position peaked at $5.61M in Q3 2021.
- 32 funds tracked by Wall St. Rank held Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant as of Q3 2022.
Based on Westchester Capital Management (New York)'s 13F filing for Q3 2022, filed 15 Nov 2022.